Biagi, J.J.; Cosby, R.; Bahl, M.; Elfiki, T.; Goodwin, R.; Hallet, J.; Hirmiz, K.; Mahmud, A.
Adjuvant Chemotherapy and Radiotherapy in Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Clinical Practice Guideline. Curr. Oncol. 2023, 30, 6575-6586.
https://doi.org/10.3390/curroncol30070482
AMA Style
Biagi JJ, Cosby R, Bahl M, Elfiki T, Goodwin R, Hallet J, Hirmiz K, Mahmud A.
Adjuvant Chemotherapy and Radiotherapy in Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Clinical Practice Guideline. Current Oncology. 2023; 30(7):6575-6586.
https://doi.org/10.3390/curroncol30070482
Chicago/Turabian Style
Biagi, James J., Roxanne Cosby, Mala Bahl, Tarek Elfiki, Rachel Goodwin, Julie Hallet, Khalid Hirmiz, and Aamer Mahmud.
2023. "Adjuvant Chemotherapy and Radiotherapy in Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Clinical Practice Guideline" Current Oncology 30, no. 7: 6575-6586.
https://doi.org/10.3390/curroncol30070482
APA Style
Biagi, J. J., Cosby, R., Bahl, M., Elfiki, T., Goodwin, R., Hallet, J., Hirmiz, K., & Mahmud, A.
(2023). Adjuvant Chemotherapy and Radiotherapy in Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Clinical Practice Guideline. Current Oncology, 30(7), 6575-6586.
https://doi.org/10.3390/curroncol30070482